Advertisement
Advertisement
U.S. markets open in 1 hour 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Voyager Therapeutics, Inc. (VYGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.57+0.06 (+1.09%)
At close: 04:00PM EST
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    Voyager Therapeutics Third Quarter 2022 Earnings: Beats Expectations

    Voyager Therapeutics ( NASDAQ:VYGR ) Third Quarter 2022 Results Key Financial Results Revenue: US$41.1m (up by US$39.6m...

  • Zacks

    Voyager Therapeutics (VYGR) Beats Q3 Earnings and Revenue Estimates

    Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 336.84% and 93.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Voyager Therapeutics Reports Third Quarter 2022 Financial and Operating Results

    - Voyager’s TRACERTM capsid platform validated by Pfizer option exercise - - Data characterizing a novel receptor and demonstrating low-dose potential further validate TRACER - - Pipeline programs advancing; development candidate selections for lead programs expected Q4 2022 to H1 2023 - - Conference call at 8:30 a.m. ET today - CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene the

Advertisement
Advertisement